[1]
GhavamiM., HoushyarJ., MehdizadehA., NajafipourM. and NajafipourF. 2021. Effective Reduction of Inflammatory and Coagulation Factors using Sitagliptin in Type 2 Diabetes . Iranian Red Crescent Medical Journal. 23, 3 (Mar. 2021). DOI:https://doi.org/10.32592/ircmj.2021.23.3.324.